Cargando…
Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
The p53 tumor suppressor plays a major role in controlling the initiation and development of cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 oncogene is a major negative regulator of p53 that inhibits the activity of p53 and reduces its protein stability. MDM2...
Autores principales: | Qin, Jiang-Jiang, Li, Xin, Hunt, Courtney, Wang, Wei, Wang, Hui, Zhang, Ruiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176154/ https://www.ncbi.nlm.nih.gov/pubmed/30320185 http://dx.doi.org/10.1016/j.gendis.2018.07.002 |
Ejemplares similares
-
The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013) -
Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
por: Qin, Jiang-Jiang, et al.
Publicado: (2017) -
Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
por: Gorgoulis, V. G., et al.
Publicado: (1998) -
Functional interplay between MDM2, p63/p73 and mutant p53
por: Stindt, M H, et al.
Publicado: (2015) -
The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)